Skip to main content

Articles

Page 88 of 108

  1. This report describes the isolation and characterization of three new murine mammary epithelial cell lines derived from mammary tumors from MMTV (mouse mammary tumor virus)/activated Neu + TβRII-AS (transformi...

    Authors: Anne EG Lenferink, Joanne Magoon, Christiane Cantin and Maureen D O'Connor-McCourt
    Citation: Breast Cancer Research 2004 6:R514
  2. UDP-glucuronosyltransferase (UGT) and sulfotransferase (SULT) enzymes are involved in removing sex hormones from circulation. Polymorphic variation in five UGT and SULT genes – UGT1A1 ((TA)6/(TA)7), UGT2B4 (Asp45...

    Authors: Rachel Sparks, Cornelia M Ulrich, Jeannette Bigler, Shelley S Tworoger, Yutaka Yasui, Kumar B Rajan, Peggy Porter, Frank Z Stanczyk, Rachel Ballard-Barbash, Xiaopu Yuan, Ming Gang Lin, Lynda McVarish, Erin J Aiello and Anne McTiernan
    Citation: Breast Cancer Research 2004 6:R488
  3. Activated leukocyte cell adhesion molecule (ALCAM) (CD166) is an immunoglobulin molecule that has been implicated in cell migration. The present study examined the expression of ALCAM in human breast cancer an...

    Authors: Judy A King, Solomon F Ofori-Acquah, Troy Stevens, Abu-Bakr Al-Mehdi, Oystein Fodstad and Wen G Jiang
    Citation: Breast Cancer Research 2004 6:R478
  4. Lymph node status is one of the decisive prognostic factors in breast cancer. Chemotherapy targeting regional lymphatic tissues has emerged as a promising therapy for the treatment of malignancies with a high ...

    Authors: Jianghao Chen, Ling Wang, Qing Yao, Rui Ling, Kaizong Li and Hui Wang
    Citation: Breast Cancer Research 2004 6:R474
  5. The role of specific dietary factors in breast cancer causation is not completely resolved. Results from prospective studies do not support the concept that fat intake in middle life has a major relation to br...

    Authors: Michelle D Holmes and Walter C Willett
    Citation: Breast Cancer Research 2004 6:170
  6. The present clinical trial update consists of a review of two of eight current studies (the 10981-22023 AMAROS trial and the 10994 p53 trial) of the European Organization for Research and Treatment of Cancer B...

    Authors: Emiel JT Rutgers, Philip Meijnen and Hervé Bonnefoi
    Citation: Breast Cancer Research 2004 6:165
  7. Previous epidemiologic studies suggest that women with variant cytochrome P4501A1 (CYP1A1) genotypes who smoke cigarettes are at increased risk for breast cancer.

    Authors: Yu Li, Robert C Millikan, Douglas A Bell, Lisa Cui, Chiu-Kit J Tse, Beth Newman and Kathleen Conway
    Citation: Breast Cancer Research 2004 6:R460
  8. The transcription factor hypoxia-inducible factor-1 (HIF-1) is a key regulator of the cellular response to hypoxia. Previous studies showed that concentrations of its subunit HIF-1α, as a surrogate for HIF-1 a...

    Authors: Reinhard Bos, Paul J van Diest, Petra van der Groep, Avi Shvarts, Astrid E Greijer and Elsken van der Wall
    Citation: Breast Cancer Research 2004 6:R450
  9. Oestrogen receptor α, which mediates the effect of oestrogen in target tissues, is genetically polymorphic. Because breast cancer development is dependent on oestrogenic influence, we have investigated whether...

    Authors: Sara Wedrén, Lovisa Lovmar, Keith Humphreys, Cecilia Magnusson, Håkan Melhus, Ann-Christine Syvänen, Andreas Kindmark, Ulf Landegren, Maria Lagerström Fermér, Fredrik Stiger, Ingemar Persson, John Baron and Elisabete Weiderpass
    Citation: Breast Cancer Research 2004 6:R437
  10. Pregnancy protects against breast cancer development in humans and rats. Parous rats have persistently reduced circulating levels of growth hormone, which may affect the activity of the growth hormone/insulin-...

    Authors: Gudmundur Thordarson, Nicole Slusher, Harriet Leong, Dafne Ochoa, Lakshmanaswamy Rajkumar, Raphael Guzman, Satyabrata Nandi and Frank Talamantes
    Citation: Breast Cancer Research 2004 6:R423
  11. The ataxia telangiectasia mutated (ATM) gene is a tumor suppressor gene with functions in cell cycle arrest, apoptosis, and repair of DNA double-strand breaks. Based on family studies, women heterozygous for muta...

    Authors: Rulla M Tamimi, Susan E Hankinson, Donna Spiegelman, Peter Kraft, Graham A Colditz and David J Hunter
    Citation: Breast Cancer Research 2004 6:R416
  12. Sentinel lymph node (SLN) biopsy allows identification of the first lymph node into which a primary tumor drains. In breast cancer, identification of tumor cells in the SLNs is a predictor of the tumor's metas...

    Authors: Nancy J Poindexter, Aysegul Sahin, Kelly K Hunt and Elizabeth A Grimm
    Citation: Breast Cancer Research 2004 6:R408
  13. The S100 gene family comprises more than 20 members whose protein sequences encompass at least one EF-hand Ca2+ binding motif. The expression of individual family members is not ubiquitous for all tissues and the...

    Authors: Ethan D Emberley, Leigh C Murphy and Peter H Watson
    Citation: Breast Cancer Research 2004 6:153
  14. Germline mutations in the genes BRCA1 and BRCA2 account for only a proportion of hereditary breast cancer, suggesting that additional genes contribute to hereditary breast cancer. Recently a heterozygous variant ...

    Authors: Geoffrey J Lindeman, Melody Hiew, Jane E Visvader, Jennifer Leary, Michael Field, Clara L Gaff, RJ McKinlay Gardner, Kevin Trainor, Glenice Cheetham, Graeme Suthers and Judy Kirk
    Citation: Breast Cancer Research 2004 6:R401
  15. Genetic polymorphisms in the promoter region of the tumour necrosis factor (TNF) gene can regulate gene expression and have been associated with inflammatory and malignant conditions. We have investigated two ...

    Authors: Iman AF Azmy, Saba P Balasubramanian, Anthony G Wilson, Timothy J Stephenson, Angela Cox, Nicola J Brown and Malcolm WR Reed
    Citation: Breast Cancer Research 2004 6:R395
  16. Gene promoter methylation is an important regulator of expression and is a key epigenetic factor in tumorigenesis. DNA methylation is mediated by DNA methyltransferases (DNMTs), of which three active forms hav...

    Authors: Karen G Montgomery, Mira CP Liu, Diana M Eccles and Ian G Campbell
    Citation: Breast Cancer Research 2004 6:R390
  17. The etiology of familial breast cancer is complex and involves genetic and environmental factors such as hormonal and lifestyle factors. Understanding familial aggregation is a key to understanding the causes ...

    Authors: Esther M John, John L Hopper, Jeanne C Beck, Julia A Knight, Susan L Neuhausen, Ruby T Senie, Argyrios Ziogas, Irene L Andrulis, Hoda Anton-Culver, Norman Boyd, Saundra S Buys, Mary B Daly, Frances P O'Malley, Regina M Santella, Melissa C Southey, Vickie L Venne…
    Citation: Breast Cancer Research 2004 6:R375
  18. We suggest that surgical extirpation of primary breast cancer among other effects accelerates relapse for some premenopausal node-positive patients. These accelerated relapses occur within 10 months of surgery...

    Authors: Michael Retsky, Gianni Bonadonna, Romano Demicheli, Judah Folkman, William Hrushesky and Pinuccia Valagussa
    Citation: Breast Cancer Research 2004 6:R372
  19. Mutations in BRCA1, BRCA2, ATM, TP53, CHK2 and PTEN account for many, but not all, multiple-case breast and ovarian cancer families. The histone acetyltransferase gene EP300 may function as a tumour suppressor ge...

    Authors: Ian G Campbell, David Choong and Georgia Chenevix-Trench
    Citation: Breast Cancer Research 2004 6:R366
  20. Breast cancer risk may be determined by various genetic, metabolic, and lifestyle factors that alter sex hormone metabolism. Cytochrome P450 1A2 (CYP1A2) is responsible for the metabolism of estrogens and many...

    Authors: Chi-Chen Hong, Bing-Kou Tang, Geoffrey L Hammond, David Tritchler, Martin Yaffe and Norman F Boyd
    Citation: Breast Cancer Research 2004 6:R352
  21. Mammographically dense breast tissue is a strong predictor of breast cancer risk, and is influenced by both mitogens and mutagens. One enzyme that is able to affect both the mitogenic and mutagenic characteris...

    Authors: Chi-Chen Hong, Bing-Kou Tang, Venketeshwer Rao, Sanjiv Agarwal, Lisa Martin, David Tritchler, Martin Yaffe and Norman F Boyd
    Citation: Breast Cancer Research 2004 6:R338
  22. Compromised patterns of gene expression result in genomic instability, altered patterns of gene expression and tumour formation. Specifically, aberrant DNA hypermethylation in gene promoter regions leads to ge...

    Authors: Bekim Sadikovic, Thomas R Haines, Darci T Butcher and David I Rodenhiser
    Citation: Breast Cancer Research 2004 6:R329
  23. Early clinical trials, mostly in the setting of melanoma, have shown that dendritic cells (DCs) expressing tumor antigens induce some immune responses and some clinical responses. A major difficulty is the ext...

    Authors: Eve-Marie Neidhardt-Berard, Frederic Berard, Jacques Banchereau and A Karolina Palucka
    Citation: Breast Cancer Research 2004 6:R322
  24. Overexpression of cyclooxygenase (COX-2) is commonly observed in human cancers. In a murine model of metastatic breast cancer, we observed that COX-2 expression and enzyme activity were associated with enhanced t...

    Authors: Xinrong Ma, Qingyuan Yang, Keith T Wilson, Namita Kundu, Stephen J Meltzer and Amy M Fulton
    Citation: Breast Cancer Research 2004 6:R316
  25. The S100A7 (psoriasin) gene is highly expressed in ductal carcinoma in situ (DCIS) of the breast and can be downregulated in invasive carcinoma. Persistent S100A7 expression in invasive carcinoma is associated wi...

    Authors: Ethan D Emberley, Salem Alowami, Linda Snell, Leigh C Murphy and Peter H Watson
    Citation: Breast Cancer Research 2004 6:R308
  26. Inflammatory breast cancer is a special type of locally advanced mammary cancer that is associated with particularly aggressive behaviour and poor prognosis. The dog was considered the only natural model in wh...

    Authors: M Dolores Pérez-Alenza, Ángeles Jiménez, Ana I Nieto and Laura Peña
    Citation: Breast Cancer Research 2004 6:R300
  27. The present study was conducted to examine the effect of conjugated docosahexaenoic acid (CDHA) on cell growth, cell cycle progression, mode of cell death, and expression of cell cycle regulatory and/or apopto...

    Authors: Miki Tsujita-Kyutoku, Takashi Yuri, Naoyuki Danbara, Hideto Senzaki, Yasuhiko Kiyozuka, Norihisa Uehara, Hideho Takada, Takahiko Hada, Teruo Miyazawa, Yutaka Ogawa and Airo Tsubura
    Citation: Breast Cancer Research 2004 6:R291
  28. A founder mutation in the BRCA2 gene (BRCA2 999del5) accounts for 7–8% of female breast cancers and for 40% of male breast cancers in Iceland. If expressed, the mutant gene would encode a protein consisting of th...

    Authors: Evgenia K Mikaelsdottir, Sigridur Valgeirsdottir, Jorunn E Eyfjord and Thorunn Rafnar
    Citation: Breast Cancer Research 2004 6:R284
  29. The purpose of the present study was to determine whether cytotoxic chemotherapeutic agents administered prior to immunotherapy with gene vaccines could augment the efficacy of the vaccines.

    Authors: Yesim Eralp, Xiaoyan Wang, Jian-Ping Wang, Maureen F Maughan, John M Polo and Lawrence B Lachman
    Citation: Breast Cancer Research 2004 6:R275
  30. A polymorphism in the manganese superoxide dismutase (MnSOD) gene, Ala-9Val, has been examined in association with breast cancer risk in several epidemiologic studies. Results suggest that the Ala allele increase...

    Authors: Robert C Millikan, Jon Player, Allan René de Cotret, Patricia Moorman, Gary Pittman, Vani Vannappagari, Chiu-Kit J Tse and Temitope Keku
    Citation: Breast Cancer Research 2004 6:R264
  31. There is evidence that diets which contain high levels of phytoestrogenic isoflavanoids are associated with a low incidence of osteoporosis and menopausal vasomotor symptoms. Plant extracts such as red clover,...

    Authors: Trevor Powles
    Citation: Breast Cancer Research 2004 6:140
  32. The overexpression of the ErbB family of tyrosine kinase receptors is thought to be important in the development of many breast tumours. To date, most attention has focused on the ErbB2 receptor. Now, in a rec...

    Authors: Elena Perez-Nadales and Alison C Lloyd
    Citation: Breast Cancer Research 2004 6:137
  33. Little is known of the function and clinical significance of intratumoral dysregulation of xenobiotic-metabolizing enzyme expression in breast cancer. One molecular mechanism proposed to explain tamoxifen resi...

    Authors: Ivan Bièche, Igor Girault, Estelle Urbain, Sengül Tozlu and Rosette Lidereau
    Citation: Breast Cancer Research 2004 6:R252
  34. Although the effects of progesterone on cell cycle progression are well known, its role in spreading and adhesion of breast cancer cells has not attracted much attention until recently. Indeed, by controlling ...

    Authors: Haiyan Pang, Brian G Rowan, Mariam Al-Dhaheri and Lee E Faber
    Citation: Breast Cancer Research 2004 6:R239
  35. Phytoestrogens are polyphenol compounds of plant origin that exhibit a structural similarity to the mammalian steroid hormone 17β-oestradiol. In Asian nations the staple consumption of phyto-oestrogen-rich foo...

    Authors: Jane L Limer and Valerie Speirs
    Citation: Breast Cancer Research 2004 6:119
  36. Transforming growth factor (TGF)-β1 is proposed to inhibit the growth of epithelial cells in early tumorigenesis, and to promote tumor cell motility and invasion in the later stages of carcinogenesis through t...

    Authors: Kimberly A Brown, Mary E Aakre, Agnieska E Gorska, James O Price, Sakina E Eltom, Jennifer A Pietenpol and Harold L Moses
    Citation: Breast Cancer Research 2004 6:R215
  37. The aim of the present article is to investigate effects of hormone replacement therapy (HRT) on contrast medium enhancement patterns in postmenopausal patients during magnetic resonance mammography (MRM).

    Authors: Stefan OR Pfleiderer, Steffen Sachse, Dieter Sauner, Christiane Marx, Ansgar Malich, Susanne Wurdinger and Werner A Kaiser
    Citation: Breast Cancer Research 2004 6:R232
  38. A multitude of molecules involved in breast cancer biology have been studied as potential prognostic markers. In the present review we discuss the role of established molecular markers, as well as potential ap...

    Authors: Francisco J Esteva and Gabriel N Hortobagyi
    Citation: Breast Cancer Research 2004 6:109

Annual Journal Metrics

  • 2022 Citation Impact
    7.4 - 2-year Impact Factor
    7.4 - 5-year Impact Factor
    1.764 - SNIP (Source Normalized Impact per Paper)
    2.408 - SJR (SCImago Journal Rank)

    2023 Speed
    20 days submission to first editorial decision for all manuscripts (Median)
    129 days submission to accept (Median)

    2023 Usage 
    2,432,781 downloads
    1,561 Altmetric mentions